Global Peptides Biosimilars Market Research Report 2023

Report ID: 1897224 | Published Date: Oct 2024 | No. of Page: 86 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Peptides Biosimilars Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Glucagon
        1.2.3 Calcitonin
    1.3 Market by Application
        1.3.1 Global Peptides Biosimilars Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Oncology
        1.3.3 Chronic Diseases
        1.3.4 Autoimmune Diseases
        1.3.5 Blood Disorders
        1.3.6 Growth Hormone Deficiency
        1.3.7 Infectious Diseases
        1.3.8 Other Diseases
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Peptides Biosimilars Market Perspective (2017-2028)
    2.2 Peptides Biosimilars Growth Trends by Region
        2.2.1 Peptides Biosimilars Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Peptides Biosimilars Historic Market Size by Region (2017-2022)
        2.2.3 Peptides Biosimilars Forecasted Market Size by Region (2023-2028)
    2.3 Peptides Biosimilars Market Dynamics
        2.3.1 Peptides Biosimilars Industry Trends
        2.3.2 Peptides Biosimilars Market Drivers
        2.3.3 Peptides Biosimilars Market Challenges
        2.3.4 Peptides Biosimilars Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Peptides Biosimilars Players by Revenue
        3.1.1 Global Top Peptides Biosimilars Players by Revenue (2017-2022)
        3.1.2 Global Peptides Biosimilars Revenue Market Share by Players (2017-2022)
    3.2 Global Peptides Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Peptides Biosimilars Revenue
    3.4 Global Peptides Biosimilars Market Concentration Ratio
        3.4.1 Global Peptides Biosimilars Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Peptides Biosimilars Revenue in 2021
    3.5 Peptides Biosimilars Key Players Head office and Area Served
    3.6 Key Players Peptides Biosimilars Product Solution and Service
    3.7 Date of Enter into Peptides Biosimilars Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Peptides Biosimilars Breakdown Data by Type
    4.1 Global Peptides Biosimilars Historic Market Size by Type (2017-2022)
    4.2 Global Peptides Biosimilars Forecasted Market Size by Type (2023-2028)
5 Peptides Biosimilars Breakdown Data by Application
    5.1 Global Peptides Biosimilars Historic Market Size by Application (2017-2022)
    5.2 Global Peptides Biosimilars Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Peptides Biosimilars Market Size (2017-2028)
    6.2 North America Peptides Biosimilars Market Size by Country (2017-2022)
    6.3 North America Peptides Biosimilars Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Peptides Biosimilars Market Size (2017-2028)
    7.2 Europe Peptides Biosimilars Market Size by Country (2017-2022)
    7.3 Europe Peptides Biosimilars Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Peptides Biosimilars Market Size (2017-2028)
    8.2 Asia-Pacific Peptides Biosimilars Market Size by Country (2017-2022)
    8.3 Asia-Pacific Peptides Biosimilars Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Peptides Biosimilars Market Size (2017-2028)
    9.2 Latin America Peptides Biosimilars Market Size by Country (2017-2022)
    9.3 Latin America Peptides Biosimilars Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Peptides Biosimilars Market Size (2017-2028)
    10.2 Middle East & Africa Peptides Biosimilars Market Size by Country (2017-2022)
    10.3 Middle East & Africa Peptides Biosimilars Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Sandoz
        11.1.1 Sandoz Company Detail
        11.1.2 Sandoz Business Overview
        11.1.3 Sandoz Peptides Biosimilars Introduction
        11.1.4 Sandoz Revenue in Peptides Biosimilars Business (2017-2022)
        11.1.5 Sandoz Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Detail
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Peptides Biosimilars Introduction
        11.2.4 Pfizer Revenue in Peptides Biosimilars Business (2017-2022)
        11.2.5 Pfizer Recent Development
    11.3 Teva Pahrmaceutical
        11.3.1 Teva Pahrmaceutical Company Detail
        11.3.2 Teva Pahrmaceutical Business Overview
        11.3.3 Teva Pahrmaceutical Peptides Biosimilars Introduction
        11.3.4 Teva Pahrmaceutical Revenue in Peptides Biosimilars Business (2017-2022)
        11.3.5 Teva Pahrmaceutical Recent Development
    11.4 Celltrion
        11.4.1 Celltrion Company Detail
        11.4.2 Celltrion Business Overview
        11.4.3 Celltrion Peptides Biosimilars Introduction
        11.4.4 Celltrion Revenue in Peptides Biosimilars Business (2017-2022)
        11.4.5 Celltrion Recent Development
    11.5 Biocon
        11.5.1 Biocon Company Detail
        11.5.2 Biocon Business Overview
        11.5.3 Biocon Peptides Biosimilars Introduction
        11.5.4 Biocon Revenue in Peptides Biosimilars Business (2017-2022)
        11.5.5 Biocon Recent Development
    11.6 Amgen
        11.6.1 Amgen Company Detail
        11.6.2 Amgen Business Overview
        11.6.3 Amgen Peptides Biosimilars Introduction
        11.6.4 Amgen Revenue in Peptides Biosimilars Business (2017-2022)
        11.6.5 Amgen Recent Development
    11.7 Samsung Biologics
        11.7.1 Samsung Biologics Company Detail
        11.7.2 Samsung Biologics Business Overview
        11.7.3 Samsung Biologics Peptides Biosimilars Introduction
        11.7.4 Samsung Biologics Revenue in Peptides Biosimilars Business (2017-2022)
        11.7.5 Samsung Biologics Recent Development
    11.8 Mylan
        11.8.1 Mylan Company Detail
        11.8.2 Mylan Business Overview
        11.8.3 Mylan Peptides Biosimilars Introduction
        11.8.4 Mylan Revenue in Peptides Biosimilars Business (2017-2022)
        11.8.5 Mylan Recent Development
    11.9 Dr. Reddy's Laboratories
        11.9.1 Dr. Reddy's Laboratories Company Detail
        11.9.2 Dr. Reddy's Laboratories Business Overview
        11.9.3 Dr. Reddy's Laboratories Peptides Biosimilars Introduction
        11.9.4 Dr. Reddy's Laboratories Revenue in Peptides Biosimilars Business (2017-2022)
        11.9.5 Dr. Reddy's Laboratories Recent Development
    11.10 Stada Arzneimittel AG
        11.10.1 Stada Arzneimittel AG Company Detail
        11.10.2 Stada Arzneimittel AG Business Overview
        11.10.3 Stada Arzneimittel AG Peptides Biosimilars Introduction
        11.10.4 Stada Arzneimittel AG Revenue in Peptides Biosimilars Business (2017-2022)
        11.10.5 Stada Arzneimittel AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Peptides Biosimilars Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Glucagon
    Table 3. Key Players of Calcitonin
    Table 4. Global Peptides Biosimilars Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Peptides Biosimilars Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Peptides Biosimilars Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Peptides Biosimilars Market Share by Region (2017-2022)
    Table 8. Global Peptides Biosimilars Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Peptides Biosimilars Market Share by Region (2023-2028)
    Table 10. Peptides Biosimilars Market Trends
    Table 11. Peptides Biosimilars Market Drivers
    Table 12. Peptides Biosimilars Market Challenges
    Table 13. Peptides Biosimilars Market Restraints
    Table 14. Global Peptides Biosimilars Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Peptides Biosimilars Market Share by Players (2017-2022)
    Table 16. Global Top Peptides Biosimilars Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptides Biosimilars as of 2021)
    Table 17. Ranking of Global Top Peptides Biosimilars Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Peptides Biosimilars Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Peptides Biosimilars Product Solution and Service
    Table 21. Date of Enter into Peptides Biosimilars Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Peptides Biosimilars Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Peptides Biosimilars Revenue Market Share by Type (2017-2022)
    Table 25. Global Peptides Biosimilars Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Peptides Biosimilars Revenue Market Share by Type (2023-2028)
    Table 27. Global Peptides Biosimilars Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Peptides Biosimilars Revenue Market Share by Application (2017-2022)
    Table 29. Global Peptides Biosimilars Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Peptides Biosimilars Revenue Market Share by Application (2023-2028)
    Table 31. North America Peptides Biosimilars Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Peptides Biosimilars Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Peptides Biosimilars Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Peptides Biosimilars Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Peptides Biosimilars Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Peptides Biosimilars Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Peptides Biosimilars Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Peptides Biosimilars Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Peptides Biosimilars Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Peptides Biosimilars Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Sandoz Company Detail
    Table 42. Sandoz Business Overview
    Table 43. Sandoz Peptides Biosimilars Product
    Table 44. Sandoz Revenue in Peptides Biosimilars Business (2017-2022) & (US$ Million)
    Table 45. Sandoz Recent Development
    Table 46. Pfizer Company Detail
    Table 47. Pfizer Business Overview
    Table 48. Pfizer Peptides Biosimilars Product
    Table 49. Pfizer Revenue in Peptides Biosimilars Business (2017-2022) & (US$ Million)
    Table 50. Pfizer Recent Development
    Table 51. Teva Pahrmaceutical Company Detail
    Table 52. Teva Pahrmaceutical Business Overview
    Table 53. Teva Pahrmaceutical Peptides Biosimilars Product
    Table 54. Teva Pahrmaceutical Revenue in Peptides Biosimilars Business (2017-2022) & (US$ Million)
    Table 55. Teva Pahrmaceutical Recent Development
    Table 56. Celltrion Company Detail
    Table 57. Celltrion Business Overview
    Table 58. Celltrion Peptides Biosimilars Product
    Table 59. Celltrion Revenue in Peptides Biosimilars Business (2017-2022) & (US$ Million)
    Table 60. Celltrion Recent Development
    Table 61. Biocon Company Detail
    Table 62. Biocon Business Overview
    Table 63. Biocon Peptides Biosimilars Product
    Table 64. Biocon Revenue in Peptides Biosimilars Business (2017-2022) & (US$ Million)
    Table 65. Biocon Recent Development
    Table 66. Amgen Company Detail
    Table 67. Amgen Business Overview
    Table 68. Amgen Peptides Biosimilars Product
    Table 69. Amgen Revenue in Peptides Biosimilars Business (2017-2022) & (US$ Million)
    Table 70. Amgen Recent Development
    Table 71. Samsung Biologics Company Detail
    Table 72. Samsung Biologics Business Overview
    Table 73. Samsung Biologics Peptides Biosimilars Product
    Table 74. Samsung Biologics Revenue in Peptides Biosimilars Business (2017-2022) & (US$ Million)
    Table 75. Samsung Biologics Recent Development
    Table 76. Mylan Company Detail
    Table 77. Mylan Business Overview
    Table 78. Mylan Peptides Biosimilars Product
    Table 79. Mylan Revenue in Peptides Biosimilars Business (2017-2022) & (US$ Million)
    Table 80. Mylan Recent Development
    Table 81. Dr. Reddy's Laboratories Company Detail
    Table 82. Dr. Reddy's Laboratories Business Overview
    Table 83. Dr. Reddy's Laboratories Peptides Biosimilars Product
    Table 84. Dr. Reddy's Laboratories Revenue in Peptides Biosimilars Business (2017-2022) & (US$ Million)
    Table 85. Dr. Reddy's Laboratories Recent Development
    Table 86. Stada Arzneimittel AG Company Detail
    Table 87. Stada Arzneimittel AG Business Overview
    Table 88. Stada Arzneimittel AG Peptides Biosimilars Product
    Table 89. Stada Arzneimittel AG Revenue in Peptides Biosimilars Business (2017-2022) & (US$ Million)
    Table 90. Stada Arzneimittel AG Recent Development
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Peptides Biosimilars Market Share by Type: 2021 VS 2028
    Figure 2. Glucagon Features
    Figure 3. Calcitonin Features
    Figure 4. Global Peptides Biosimilars Market Share by Application in 2021 & 2028
    Figure 5. Oncology Case Studies
    Figure 6. Chronic Diseases Case Studies
    Figure 7. Autoimmune Diseases Case Studies
    Figure 8. Blood Disorders Case Studies
    Figure 9. Growth Hormone Deficiency Case Studies
    Figure 10. Infectious Diseases Case Studies
    Figure 11. Other Diseases Case Studies
    Figure 12. Peptides Biosimilars Report Years Considered
    Figure 13. Global Peptides Biosimilars Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Peptides Biosimilars Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Peptides Biosimilars Market Share by Region: 2021 VS 2028
    Figure 16. Global Peptides Biosimilars Market Share by Players in 2021
    Figure 17. Global Top Peptides Biosimilars Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptides Biosimilars as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Peptides Biosimilars Revenue in 2021
    Figure 19. North America Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Peptides Biosimilars Market Share by Country (2017-2028)
    Figure 21. United States Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Peptides Biosimilars Market Share by Country (2017-2028)
    Figure 25. Germany Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Peptides Biosimilars Market Share by Region (2017-2028)
    Figure 33. China Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Peptides Biosimilars Market Share by Country (2017-2028)
    Figure 41. Mexico Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Peptides Biosimilars Market Share by Country (2017-2028)
    Figure 45. Turkey Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Peptides Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Sandoz Revenue Growth Rate in Peptides Biosimilars Business (2017-2022)
    Figure 48. Pfizer Revenue Growth Rate in Peptides Biosimilars Business (2017-2022)
    Figure 49. Teva Pahrmaceutical Revenue Growth Rate in Peptides Biosimilars Business (2017-2022)
    Figure 50. Celltrion Revenue Growth Rate in Peptides Biosimilars Business (2017-2022)
    Figure 51. Biocon Revenue Growth Rate in Peptides Biosimilars Business (2017-2022)
    Figure 52. Amgen Revenue Growth Rate in Peptides Biosimilars Business (2017-2022)
    Figure 53. Samsung Biologics Revenue Growth Rate in Peptides Biosimilars Business (2017-2022)
    Figure 54. Mylan Revenue Growth Rate in Peptides Biosimilars Business (2017-2022)
    Figure 55. Dr. Reddy's Laboratories Revenue Growth Rate in Peptides Biosimilars Business (2017-2022)
    Figure 56. Stada Arzneimittel AG Revenue Growth Rate in Peptides Biosimilars Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sandoz
Pfizer
Teva Pahrmaceutical
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy's Laboratories
Stada Arzneimittel AG
Frequently Asked Questions
Peptides Biosimilars report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Peptides Biosimilars report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Peptides Biosimilars report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Sandblasting Media

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More